Join to View Full Profile
1717 6th Ave SBirmingham, AL 35233
Phone+1 800-822-8816
Dr. Sudarshan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Medical University of South CarolinaResidency, Urology, 2002 - 2005
- Medical University of South Carolina College of MedicineInternship, Transitional Year, 2001 - 2002
- Duke University School of MedicineClass of 1999
Certifications & Licensure
- AL State Medical License 2012 - 2025
- TX State Medical License 2007 - 2012
- SC State Medical License 2005 - 2007
- American Board of Urology Urology
Clinical Trials
- Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- 2 citationsMYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development.Jane Ding, Mohit Bansal, Yuxia Cao, Bingwei Ye, Rui Mao
Cancer Research. 2024-12-02 - Renal L-2-hydroxyglutarate dehydrogenase activity promotes hypoxia tolerance and mitochondrial metabolism in Drosophila melanogaster.Nader H Mahmoudzadeh, Yasaman Heidarian, Jason P Tourigny, Alexander J Fitt, Katherine Beebe
Molecular Metabolism. 2024-11-01 - 1 citationsl-2-Hydroxyglutarate remodeling of the epigenome and epitranscriptome creates a metabolic vulnerability in kidney cancer models.Anirban Kundu, Garrett J Brinkley, Hyeyoung Nam, Suman Karki, Richard Kirkman
The Journal of Clinical Investigation. 2024-05-14
Press Mentions
- 2020 Urology Care Foundation Research Scholar Awardees AnnouncedFebruary 11th, 2020
Grant Support
- Interaction between the Epitranscriptome and Metabolism in L-2HG Driven Kidney CancerUNIVERSITY OF ALABAMA AT BIRMINGHAM2016–2027
- Interaction between the Epitranscriptome and Metabolism in L-2HG Driven Kidney CancerUNIVERSITY OF ALABAMA AT BIRMINGHAM2016–2027
- Interaction between the Epitranscriptome and Metabolism in L-2HG Driven Kidney CancerUNIVERSITY OF ALABAMA AT BIRMINGHAM2016–2027
- HDAC7-driven metabolic remodeling in renal tumor progressionBIRMINGHAM VA MEDICAL CENTER2015–2027
- HDAC7-driven metabolic remodeling in renal tumor progressionBIRMINGHAM VA MEDICAL CENTER2015–2027
- Role Of Fumarate Hydratase In Renal Hypoxia And TumorigenesisNational Cancer Institute2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
